SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 415.52 |
Enterprise Value ($M) | 378.72 |
Book Value ($M) | 138.40 |
Book Value / Share | 1.01 |
Price / Book | 3.00 |
NCAV ($M) | 130.39 |
NCAV / Share | 0.95 |
Price / NCAV | 3.19 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.33 |
Return on Assets (ROA) | -0.30 |
Return on Equity (ROE) | -0.32 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 31.84 |
Current Ratio | 31.84 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 141.14 |
Assets | 149.15 |
Liabilities | 10.75 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Tang Capital Management Llc | |||
13G/A | Janus Henderson Group Plc | 1.30 | -75.90 | |
13G | Blackstone Holdings II L.P. | 6.90 | ||
13D/A | Orbimed Advisors Llc | 13.70 | 0.00 | |
13G/A | Fmr Llc | 3.57 | -28.38 | |
13G/A | Adage Capital Partners Gp, L.l.c. | 7.75 | 37.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
253,418 | 1,003,322 | 25.26 | |
157,576 | 685,199 | 23.00 | |
682,361 | 2,071,110 | 32.95 | |
935,928 | 3,910,608 | 23.93 | |
238,703 | 1,498,711 | 15.93 | |
(click for more detail) |
Similar Companies | |
---|---|
CLDX – Celldex Therapeutics, Inc. | CLNN – Clene Inc. |
CLRB – Cellectar Biosciences, Inc. | CNSP – CNS Pharmaceuticals, Inc. |
CNTX – Context Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io